ESPR
Esperion Therapeutics, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$3.18
+0.00%Leverage
- Debt / equity
- -1.77x
- Net debt / equity
- -1.26x
- Debt / assets
- 1.18x
- Debt / EBITDA
- 13.63x
- Net debt / EBITDA
- 9.72x
Liquidity & coverage
- Current ratio
- 1.53x
- Quick ratio
- 1.18x
- Cash ratio
- 0.52x
- Interest coverage
- 1.67x
- EBITDA / interest
- 0.88x
- Working capital
- $159.1M
Cash & dividend
- FCF / debt
- -0.03x
- Cash flow / debt
- -0.03x
- Dividend per share
- $3.16
- Dividend yield
- 99.4%
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026